Jayaram, Anuradha
Attard, Gerhardt
Article History
First Online: 26 May 2015
Competing interests
: G.A. declares that he has received consulting fees from Astellas, Janssen–Cilag, Millennium Pharmaceuticals, Novartis, Sanofi–Aventis and Veridex, lecture fees from Ipsen, Janssen–Cilag, and Sanofi–Aventis, and grant support from AstraZeneca and Janssen. G.A. is on the Institute of Cancer Research rewards to inventors list of abiraterone acetate. Abiraterone acetate was developed at The Institute of Cancer Research, which therefore has a commercial interest in the development of this agent. A.J. declares no competing interests.